Skip to content
Menu

Kyntra Bio, Inc. KYNB

Full chart Compare
Set alert

Price alert · KYNB

All alert types
3.33 USD -0.16 (-4.58%)

As ofNov 16, 2026, 1:00 PM EST

3.02 Day range 3.74
3.02 52-week range 10.47
YTD
-62.07%
1 year
-61.68%

KYNB revenue history

Revenue is income from the company’s ordinary business activities.

6,440,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-316,440,000-23,181,000-78.26%
FY 20242024-12-3129,621,000-17,182,000-36.71%
FY 20232023-12-3146,803,000-93,931,000-66.74%
FY 20222022-12-31140,734,000-94,575,000-40.19%
FY 20212021-12-31235,309,00058,990,00033.46%
FY 20202020-12-31176,319,000-80,258,000-31.28%
FY 20192019-12-31256,577,00043,619,00020.48%
FY 20182018-12-31212,958,00081,962,00062.57%
FY 20172017-12-31130,996,000-52,193,000-28.49%
FY 20162016-12-31183,189,0002,361,0001.31%
FY 20152015-12-31180,828,00043,227,00031.41%
FY 20142014-12-31137,601,00035,431,00034.68%
FY 20132013-12-31102,170,00036,237,00054.96%
FY 20122012-12-3165,933,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-22T14:43:48.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.